Corcept Therapeutics (CORT) EPS (Diluted) (2014 - 2026)
Corcept Therapeutics' EPS (Diluted) came in at $1.01 for Q3 2026, up 523.4% from $0.16 a year earlier and up 183.9% from the prior quarter.
Powered by 
Analysis
Corcept Therapeutics (CORT) EPS (Diluted) (2014 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Corcept Therapeutics reported EPS (Diluted) of $1.29, up 47.6% year-over-year; for FY2025, it came in at $0.82, down 33.6% from FY2024.
- EPS (Diluted) carries a five-year compound annual growth rate of -0.8% (FY2020 to FY2025).
- Going back by year, EPS (Diluted) was $1.23 in FY2024 (+30.4%), $0.94 in FY2023 (+8.1%), $0.87 in FY2022 (-2.2%) and $0.89 in FY2021 (+4.6%).
- The Q3 2026 figure represents the highest quarterly EPS (Diluted) in data going back to Q4 2014.
- Year-over-year, EPS (Diluted) increased in two of the last seven quarters, with growth averaging 59.4%.
- The fastest year-over-year change in EPS (Diluted) over five years came in Q3 2026 (growth of 523.4%), and the weakest in Q3 2025 (a decline of 60.5%).
- Business Quant data shows CORT's EPS (Diluted) at $0.36 (Q2 2026), -$0.30 (Q1 2026) and $0.20 (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 7.22 |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 0.09 |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 2.38 |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 2.04 |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 2.00 |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 7.08 |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 1.94 |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 0.56 |
| 10 | Corcept Therapeutics | 7.99 Bn | 6.60 Bn | 335.86 Mn | 1.01 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.01 |
| Jun 30, 2026 | 0.36 |
| Mar 31, 2026 | -0.30 |
| Dec 31, 2025 | 0.20 |
| Sep 30, 2025 | 0.16 |
| Jun 30, 2025 | 0.29 |
| Mar 31, 2025 | 0.17 |
| Dec 31, 2024 | 0.27 |
| Sep 30, 2024 | 0.41 |
| Jun 30, 2024 | 0.32 |
| Mar 31, 2024 | 0.25 |
| Dec 31, 2023 | 0.28 |
| Sep 30, 2023 | 0.28 |
| Jun 30, 2023 | 0.25 |
| Mar 31, 2023 | 0.14 |
| Dec 31, 2022 | 0.14 |
| Sep 30, 2022 | 0.30 |
| Jun 30, 2022 | 0.24 |
| Mar 31, 2022 | 0.20 |
| Dec 31, 2021 | 0.25 |
API Access
Corcept Therapeutics EPS (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-diluted&ticker=CORT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-diluted", "ticker": "CORT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-diluted&ticker=CORT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();